Skip header and navigation

Refine By

31995 records – page 1 of 3200.

Impact of vaccination on selected diseases in Canada.

https://arctichealth.org/en/permalink/ahliterature239040
Source
Can Med Assoc J. 1985 Mar 15;132(6):635-9
Publication Type
Article
Date
Mar-15-1985
Author
S E Acres
P V Varughese
Source
Can Med Assoc J. 1985 Mar 15;132(6):635-9
Date
Mar-15-1985
Language
English
Publication Type
Article
Keywords
Canada
Diphtheria - prevention & control
Humans
Immunization
Measles - prevention & control
Poliomyelitis - immunology - prevention & control
Rubella - prevention & control
Tetanus - prevention & control
Tuberculosis - prevention & control
Whooping Cough - prevention & control
Abstract
Vaccination has dramatically reduced the morbidity and mortality rates of a number of diseases. The crucial element of vaccination programs is commitment to widespread coverage and to containment of outbreaks. Vaccines have led to virtual elimination of poliomyelitis and promise to eliminate measles. The incidence of congenital rubella syndrome will probably only be diminished if vaccination is extended to all 1-year-olds and susceptible prepubertal girls. The employment of diphtheria toxoid is one of the great success stories in public health. The incidence of pertussis has declined because of the diphtheria-pertussis-tetanus (DPT) vaccine given to infants, although elimination of the disease will probably have to await development of a more potent pertussis antigen. A remarkable reduction in the incidence of tetanus and tuberculosis has also been achieved.
Notes
Cites: Rev Infect Dis. 1984 Jul-Aug;6(4):528-316474012
PubMed ID
3978483 View in PubMed
Less detail

[Preventive dentistry program. Practical preventive dentistry: 15-year experience in Sweden].

https://arctichealth.org/en/permalink/ahliterature231494
Source
Schweiz Monatsschr Zahnmed. 1989;99(9):1045-51
Publication Type
Article
Date
1989

[Periodic medical examination. Update 1990: 3. Interventions looking to prevent cancer of the lung using other methods than smoking cessation. The Canadian Study Group for Periodic Medical Examination].

https://arctichealth.org/en/permalink/ahliterature226703
Source
Union Med Can. 1991 Mar-Apr;120(2):61-3
Publication Type
Article

The multifactor primary prevention trial in Göteborg, Sweden.

https://arctichealth.org/en/permalink/ahliterature55625
Source
Eur Heart J. 1986 Apr;7(4):279-88
Publication Type
Article
Date
Apr-1986
Author
L. Wilhelmsen
G. Berglund
D. Elmfeldt
G. Tibblin
H. Wedel
K. Pennert
A. Vedin
C. Wilhelmsson
L. Werkö
Source
Eur Heart J. 1986 Apr;7(4):279-88
Date
Apr-1986
Language
English
Publication Type
Article
Keywords
Aged
Cerebrovascular Disorders - prevention & control
Coronary Disease - prevention & control
Humans
Hypercholesterolemia - prevention & control
Hypertension - prevention & control
Male
Middle Aged
Primary Prevention
Risk
Smoking - prevention & control
Sweden
Abstract
The effect of a multifactorial intervention programme on coronary heart disease (CHD), stroke incidence and total mortality was determined in a random sample of men, 47-55 years old at entry. The intervention group comprised 10 004 men, and the two control groups were of similar size. The intervention consisted of antihypertensive treatment in subjects with screening blood pressure above 175 mmHg systolic or 115 mmHg diastolic, dietary advice to men with serum cholesterol levels above 260 mg per 100 ml (= 6.8 mMol l-1), advice to stop smoking to subjects who smoked more than 15 cigarettes per day. The intervention was applied for 10 years during which time CHD and stroke incidence and mortality were followed by means of special registers. Participation rate at first screening examination was 75%. The risk factor levels, i.e. blood pressure, serum cholesterol and smoking decreased markedly during 10 years in the intervention group, but also among the control groups. Total mortality, stroke and CHD incidence did not differ significantly between the intervention group and any of the two control groups. We conclude that a decrease has taken place in all three major risk factors for CHD in the general male population in Göteborg, Sweden. Strategies other than intervention on high-risk individuals must be chosen if a major impact on disease incidence is to be achieved in the general population.
PubMed ID
3720755 View in PubMed
Less detail

Vaccination against Staphylococcus aureus mastitis in two Swedish dairy herds.

https://arctichealth.org/en/permalink/ahliterature276783
Source
Acta Vet Scand. 2015 Nov 25;57:81
Publication Type
Article
Date
Nov-25-2015
Author
Håkan Landin
Marie Jansson Mörk
Maria Larsson
Karin Persson Waller
Source
Acta Vet Scand. 2015 Nov 25;57:81
Date
Nov-25-2015
Language
English
Publication Type
Article
Keywords
Animals - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Cattle - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Cattle Diseases - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Dairying - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Female - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Lactation - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Longevity - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Mammary Glands, Animal - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Mastitis, Bovine - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Milk - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Staphylococcal Infections - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Staphylococcal Vaccines - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Staphylococcus aureus - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Sweden - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Vaccination - microbiology - prevention & control - physiology - physiopathology - microbiology - prevention & control - secretion - microbiology - prevention & control - veterinary - administration & dosage - immunology - veterinary
Abstract
Staphylococcus aureus is a common udder pathogen in dairy cows, and may cause severe mastitis problems in some herds. In herds where normal control measures are not successful, vaccination might be an additional tool to use if sufficiently efficient. The aim of the present study was to evaluate the efficacy of a commercially available vaccine (Startvac(?), Hipra, Spain) in two commercial Swedish dairy herds where the control programs for S. aureus mastitis had been unsuccessful. Within each herd cows were randomly assigned to vaccine or control groups, and effects on udder health and milk production during 120 days after calving, and survival during the following lactation were evaluated.
A field study was performed in two high producing Swedish herds having approximately 600 (herd A) and 200 (herd B) cows. During 12 months, cows with odd numbers were vaccinated three times around calving according to label protocol, while cows with even numbers constituted the not vaccinated control group. Quarter milk samples for bacteriological culturing were collected from all cases of clinical and subclinical mastitis. The outcome was evaluated during 120 days after calving using data on SCC and daily milk yield at monthly milk recordings, and incidence of mastitis due to S. aureus, coagulase-negative staphylococci, streptococci and coliforms. Cow survival throughout lactation was also studied. In herd A, 239 and 240 cows were included in the vaccinated and control groups, respectively. Corresponding numbers for herd B was 126 and 151 cows. Significant differences between vaccinated and control groups were not found in any of the parameters investigated.
Vaccination with a commercial polyvalent vaccine did not have any beneficial effects on udder health, milk production or survival in two commercial dairy herds with mastitis problems due to S. aureus.
Notes
Cites: J Clin Microbiol. 2005 Sep;43(9):4737-4316145135
Cites: J Dairy Sci. 2006 Jun;89(6):1877-9516702252
Cites: Acta Vet Scand. 2011;53:3621649936
Cites: Vaccine. 2009 Apr 14;27(17):2379-8619428854
Cites: Vet Immunol Immunopathol. 2010 Apr 15;134(3-4):208-1719836084
Cites: J Dairy Sci. 2015 Mar;98(3):1706-2025529419
Cites: Vet Microbiol. 2011 Mar 24;148(2-4):117-2421115309
Cites: Vet Microbiol. 2009 May 28;137(1-2):90-719155148
Cites: Vet Clin North Am Food Anim Pract. 2012 Jul;28(2):203-1622664203
Cites: J Dairy Sci. 2014;97(8):5250-6424881797
Cites: Vet J. 2010 Aug;185(2):188-9219481482
PubMed ID
26608421 View in PubMed
Less detail

Factors affecting costs for on-farm control of salmonella in Swedish dairy herds.

https://arctichealth.org/en/permalink/ahliterature276842
Source
Acta Vet Scand. 2015 Jun 06;57:28
Publication Type
Article
Date
Jun-06-2015
Author
Estelle C C Ågren
Jan Johansson
Jenny Frössling
Helene Wahlström
Ulf Emanuelson
Susanna Sternberg-Lewerin
Source
Acta Vet Scand. 2015 Jun 06;57:28
Date
Jun-06-2015
Language
English
Publication Type
Article
Keywords
Animals - economics - microbiology - prevention & control - economics - methods - economics - microbiology - prevention & control
Cattle - economics - microbiology - prevention & control - economics - methods - economics - microbiology - prevention & control
Cattle Diseases - economics - microbiology - prevention & control - economics - methods - economics - microbiology - prevention & control
Dairying - economics - microbiology - prevention & control - economics - methods - economics - microbiology - prevention & control
Female - economics - microbiology - prevention & control - economics - methods - economics - microbiology - prevention & control
Regression Analysis - economics - microbiology - prevention & control - economics - methods - economics - microbiology - prevention & control
Salmonella Infections, Animal - economics - microbiology - prevention & control - economics - methods - economics - microbiology - prevention & control
Sweden - economics - microbiology - prevention & control - economics - methods - economics - microbiology - prevention & control
Abstract
The Swedish control program for salmonella includes restrictions and on-farm control measures when salmonella is detected in a herd. Required control measures are subsidised by the government. This provides an opportunity to study costs for on-farm salmonella control. The aim of this study was to describe the costs for on-farm salmonella control in Swedish cattle herds and to investigate the effects of herd factors on these costs in dairy herds.
During the 15 years studied there had been a total of 124 restriction periods in 118 cattle herds; 89 dairy herds, 28 specialised fattening herds and three suckler herds. The average costs per herd for on-farm salmonella control was 4.60 million SEK with a median of 1.06 million SEK corresponding to approximately 490 000 and 110 000 EUR. The range was 0.01 to 41 million SEK corresponding to 1080 EUR to 4.44 million EUR per farm. The costs cover measures required in herd-specific control plans, generally measures improving herd hygiene. A mixed linear model was used to investigate associations between herd factors and costs for on-farm salmonella control in dairy herds. Herd size and length of the restriction period were both significantly associated with costs for on-farm control of salmonella with larger herds and longer periods of restrictions leading to higher costs. Serotype detected and administrative changes in the Swedish Board of Agriculture aiming at reducing costs were not associated with costs for on-farm salmonella control.
On-farm control of salmonella in Swedish cattle herds incurred high costs but the costs also varied largely between herds. Larger herds and longer restriction periods increased the costs for on-farm control of salmonella in Swedish dairy herds. This causes concern for future costs for the Swedish salmonella control program as herd sizes are increasing.
Notes
Cites: J Appl Microbiol. 2004;96(2):311-914723692
Cites: Prev Vet Med. 2005 Sep 30;71(1-2):35-4416023233
Cites: J Appl Microbiol. 2007 Sep;103(3):650-617714398
Cites: BMC Vet Res. 2007;3:2117888169
Cites: Prev Vet Med. 2010 Mar 1;93(4):276-8519963291
Cites: Prev Vet Med. 2013 Aug 1;111(1-2):51-6223628337
Cites: PLoS One. 2014;9(5):e9644624831797
Cites: Euro Surveill. 2014;19(19). pii: 2080424852953
PubMed ID
26048281 View in PubMed
Less detail

31995 records – page 1 of 3200.